Investor Update

Basel, 20 May 2009

Roche ASCO planner

Roche and Genentech will present a large number of abstracts on their broad oncology portfolio at the Annual Meeting of American Society of Clinical Oncology (ASCO) in Orlando on May 29 – June 2.  In order to assist you, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to us, including indication of time and venue of the presentation. This planner can be downloaded from our website via

http://www.roche.com/asco-planner-2009.pdf

We will have a significant presence at the congress with more than 500 scientific abstracts to be presented across 20 types of cancers. A summary of the key data presented at ASCO will be provided at the Analyst briefings on May 31st and June 1st in Orlando, which we invite you to attend. Details can be found on:

http://www.roche.com/investors/ir_update/inv-update-2009-05-19.htm